Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanisms

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of neural transmission

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00702-006-0561-zPMID 16906354
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular studies of the neuronal nicotinic acetylcholine receptor family

  2008cited by this paper
• Cigarette Smoking and Parkinson's Disease

  2007cited by this paper
• Tropisetron improves deficits in auditory P50 suppression in schizophrenia

  2006cited by this paper
• Effects of nicotine on hippocampal and cingulate activity during smooth pursuit eye movement in schizophrenia.

  2006cited by this paper
• Long-lasting cognitive improvement with nicotinic receptor agonists: mechanisms of pharmacokinetic-pharmacodynamic discordance.

  2005cited by this paper
• Chronic Nicotine Exposure Upregulates Nicotinic Receptors by a Novel Mechanism

  2005cited by this paper
• Desensitization of nicotinic ACh receptors: shaping cholinergic signaling.

  2005cited by this paper
• Why does the rapid delivery of drugs to the brain promote addiction?

  2005cited by this paper
• Therapeutic implications of a selective alpha7 nicotinic receptor abnormality in schizophrenia.

  2005cited by this paper
• Acute intermittent nicotine treatment enhances proliferation of neuronal precursor cells in the subventricular zone (SVZ) of adult rat brain

  2005cited by this paper
• Increases in dopamine utilization in certain limbic dopamine terminal populations after a short period of intermittent exposure of male rats to cigarette smoke

  2005cited by this paper
• Nicotine upregulates its own receptors through enhanced intracellular maturation.

  2005cited by this paper
• Desensitized nicotinic receptors in brain.

  2005cited by this paper
• The choice of antipsychotic drugs for schizophrenia.

  2005cited by this paper
• μ-Opioid Receptor and CREB Activation Are Required for Nicotine Reward

  2005cited by this paper
• Transcription factor gene expression profiling after acute intermittent nicotine treatment in the rat cerebral cortex.

  2005cited by this paper
• Indicators of neuroprotection with galantamine.

  2005cited by this paper
• Tropisetron improves deficits in auditory P50 suppression in schizophrenia.

  2005cited by this paper
• Differential modulation of gene expression in the NMDA postsynaptic density of schizophrenic and control smokers.

  2005cited by this paper
• Nicotine and epibatidine triggered prolonged rise in calcium and TH gene transcription in PC12 cells.

  2004cited by this paper
• Using animal models to test a neurodevelopmental hypothesis of schizophrenia.

  2004cited by this paper
• Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders

  2004cited by this paper
• Facilitation of learning and state dependency with nicotine

  2004cited by this paper
• Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusion

  2004cited by this paper
• Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders

  2004cited by this paper
• Effects of nicotinic stimulation on cognitive performance.

  2004cited by this paper
• Nicotinic receptors and schizophrenia

  2004cited by this paper
• CRSN Symposium: Focus on Schizophrenia Symposium du CRSN : le point sur la schizophrénie Using animal models to test a neurodevelopmental hypothesis of schizophrenia

  2004cited by this paper
• Protective effects of nicotine against glutamate-induced neurotoxicity in PC12 cells.

  2004cited by this paper
• Nicotinic receptors and cognition in Parkinson’s Disease: the importance of neuronal synchrony

  2004cited by this paper
• Smoking, nicotine and Parkinson's disease.

  2004cited by this paper
• Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia

  2004cited by this paper
• Alteration of hippocampal cell proliferation in mice lacking the β2 subunit of the neuronal nicotinic acetylcholine receptor

  2004cited by this paper
• Cleavage of proBDNF by tPA/Plasmin Is Essential for Long-Term Hippocampal Plasticity

  2004cited by this paper
• Neuronal nicotinic receptors: from structure to pathology.

  2004cited by this paper
• Preventing cancer by controlling youth tobacco use.

  2003cited by this paper
• A Functional Role for Nicotine in Bcl2 Phosphorylation and Suppression of Apoptosis*

  2003cited by this paper
• In vivo nicotine treatment regulates mesocorticolimbic CREB and ERK signaling in C57Bl/6J mice

  2003cited by this paper
• Nicotinic Receptors Differentially Regulate N-Methyl-d-aspartate Damage in Acute Hippocampal Slices

  2003cited by this paper
• Loss of nicotinic acetylcholine receptor subunits α4 and α7 in the cerebral cortex of Parkinson patients

  2003cited by this paper
• Nicotine enhances contextual fear conditioning in C57BL/6J mice at 1 and 7 days post-training.

  2003cited by this paper
• Nicotine Modulates the Expression of a Diverse Set of Genes in the Neuronal SH-SY5Y Cell Line*

  2003cited by this paper
• Pharmacologic treatment of Alzheimer's disease: an update.

  2003cited by this paper
• The Subtype-Selective Nicotinic Acetylcholine Receptor Agonist SIB-1553A Improves Both Attention and Memory Components of a Spatial Working Memory Task in Chronic Low Dose 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Treated Monkeys

  2003cited by this paper
• Loss of nicotinic acetylcholine receptor subunits alpha4 and alpha7 in the cerebral cortex of Parkinson patients.

  2003cited by this paper
• Cellular and synaptic mechanisms of nicotine addiction.

  2002cited by this paper
• Hippocampal alpha 7 and alpha 4 beta 2 nicotinic receptors and working memory.

  2002cited by this paper
• The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences.

  2002cited by this paper
• Common molecular and cellular substrates of addiction and memory.

  2002cited by this paper
• Hippocampal α7 and α4β2 nicotinic receptors and working memory

  2002cited by this paper
• Nicotine increases the expression of high affinity nerve growth factor receptors in both in vitro and in vivo.

  2002influential reference
• Nicotine Self-Administration Impairs Hippocampal Plasticity

  2002cited by this paper
• Stimulation of non-alpha7 nicotinic receptors partially protects dopaminergic neurons from 1-methyl-4-phenylpyridinium-induced toxicity in culture.

  2002cited by this paper
• Cognitive mechanisms of nicotine on visual attention.

  2002cited by this paper
• The role of neuronal nicotinic acetylcholine receptors in acute and chronic neurodegeneration.

  2002cited by this paper
• Galantamine for treatment-resistant schizophrenia.

  2002cited by this paper
• Nicotinic regulation of CREB activation in hippocampal neurons by glutamatergic and nonglutamatergic pathways.

  2002cited by this paper
• Nuclear calcium signaling controls CREB-mediated gene expression triggered by synaptic activity

  2001cited by this paper
• Nicotinic receptor-mediated protection against beta-amyloid neurotoxicity.

  2001cited by this paper
• Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticity.

  2001cited by this paper
• Synaptic plasticity and nicotine addiction.

  2001cited by this paper
• The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory

  2001cited by this paper
• Alzheimer's disease and Aβ toxicity: from top to bottom

  2001cited by this paper
• Voltage-gated channels block nicotinic regulation of CREB phosphorylation and gene expression in neurons.

  2001cited by this paper
• The Molecular Biology of Memory Storage: A Dialogue Between Genes and Synapses

  2001cited by this paper
• Effects of protracted nicotine exposure and withdrawal on the expression and phosphorylation of the CREB gene transcription factor in rat brain

  2001cited by this paper
• Nicotinic receptor abnormalities in Alzheimer's disease.

  2001cited by this paper
• Overview of nicotinic receptors and their roles in the central nervous system.

  2001cited by this paper
• Relationship between the increased cell surface α7 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonists

  2001cited by this paper
• Acute and chronic nicotine exposure reverse age-related declines in the induction of long-term potentiation in the rat hippocampus.

  2001cited by this paper
• Neuronal nicotinic acetylcholine receptor subunit knockout mice: physiological and behavioral phenotypes and possible clinical implications.

  2001cited by this paper
• Drug Dependence as a Disorder of Neural Plasticity: Focus on Dopamine and Glutamate

  2001cited by this paper
• alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity.

  2001cited by this paper
• Dose‐related neuroprotective effects of chronic nicotine in 6‐hydroxydopamine treated rats, and loss of neuroprotection in α4 nicotinic receptor subunit knockout mice

  2001cited by this paper
• Stimulatory role of dopamine on fibroblast growth factor‐2 expression in rat striatum

  2001cited by this paper
• Molecular basis of long-term plasticity underlying addiction

  2001cited by this paper
• α7 Nicotinic Receptor Transduces Signals to Phosphatidylinositol 3-Kinase to Block A β-Amyloid-induced Neurotoxicity*

  2001cited by this paper
• Alzheimer's disease and Abeta toxicity: from top to bottom.

  2001cited by this paper
• Nicotinic treatment of Alzheimer's disease.

  2001cited by this paper
• Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease.

  2001cited by this paper
• Nicotine and its interaction with β-amyloid protein: a short review

  2001cited by this paper
• Nicotine and its interaction with beta-amyloid protein: a short review.

  2001cited by this paper
• The prefrontal cortex and the integration of sensory, limbic and autonomic information.

  2000cited by this paper
• Inhibition and disinhibition of pyramidal neurons by activation of nicotinic receptors on hippocampal interneurons.

  2000cited by this paper
• Allosterically potentiating ligands of nicotinic receptors as a treatment strategy for Alzheimer's disease.

  2000cited by this paper
• Smoking and Parkinson's and Alzheimer's disease: review of the epidemiological studies.

  2000cited by this paper
• The involvement of spinal Ca(2+)/calmodulin-protein kinase II in nicotine-induced antinociception in mice.

  2000cited by this paper
• Chronic treatment of old rats with donepezil or galantamine: effects on memory, hippocampal plasticity and nicotinic receptors.

  2000cited by this paper
• The brain alpha7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA (GTS-21).

  2000cited by this paper
• The effects of nicotine on Parkinson's disease.

  2000cited by this paper
• Development of nicotinic drug therapy for cognitive disorders.

  2000cited by this paper
• Central nicotinic receptors, neurotrophic factors and neuroprotection.

  2000cited by this paper
• Role of a 7 nicotinic receptors in nicotine dependence and implications for psychiatric illness

  2000cited by this paper
• Nicotine attenuates arachidonic acid-induced overexpression of nitric oxide synthase in cultured spinal cord neurons.

  2000cited by this paper
• Involvement of α7 Nicotinic Acetylcholine Receptors in Activation of Tyrosine Hydroxylase and Dopamine β‐Hydroxylase Gene Expression in PC12 Cells

  2000cited by this paper
• The α7 nicotinic acetylcholine receptor subtype mediates nicotine protection against NMDA excitotoxicity in primary hippocampal cultures through a Ca2+ dependent mechanism

  2000cited by this paper
• Involvement of alpha7 nicotinic acetylcholine receptors in activation of tyrosine hydroxylase and dopamine beta-hydroxylase gene expression in PC12 cells.

  2000cited by this paper
• Long-term potentiation of excitatory inputs to brain reward areas by nicotine.

  2000cited by this paper
• Modulatory effect of ginseng total saponin on dopamine release and tyrosine hydroxylase gene expression induced by nicotine in the rat.

  2000cited by this paper
• Cellular Expression of α7 Nicotinic Acetylcholine Receptor Protein in the Temporal Cortex in Alzheimer's and Parkinson's Disease— A Stereological Approach

  2000cited by this paper

• Generalized additive modeling as a tool for the analysis of the time course of tail coiling behavior in zebrafish (Danio rerio) embryos - A proof-of-concept study with nicotine, a known developmental neurotoxicant.

  2025cites this paper
• Cellular Mechanisms of Cognitive Enhancement: The In Vivo Modulation of the Firing Activity and the Responsiveness of Rat Hippocampal Neurons by Memantine and Alpha7 Nicotinic Acetylcholine Receptor Ligands

  2024cites this paper
• Neuroprotective and Antioxidant Role of Oxotremorine-M, a Non-selective Muscarinic Acetylcholine Receptors Agonist, in a Cellular Model of Alzheimer Disease

  2022cites this paper
• The Counteracting Performance of Phytoconstituents Against Neurodegeneration Involved in Parkinson's Disease

  2021cites this paper
• Cholinergic Receptor Modulation as a Target for Preventing Dementia in Parkinson’s Disease

  2021cites this paper
• Role of cytokine and neurotrophic factors in Nicotine Addiction in the Conditioned Place Preference Paradigm.

  2021cites this paper
• Involvement of HB-EGF/Ascl1/Lin28a Genes in Dedifferentiation of Adult Mammalian Müller Glia

  2020cites this paper
• ANALYSIS OF THE ROLE OF CENTRAL CHOLINOREACTIVITY IN EXPERIMENTAL TRAUMATIC BRAIN INJURY

  2020cites this paper
• Экспериментальное моделирование холинореактивности головного мозга при черепно-мозговой травме: влияние на центральную гемодинамику

  2020cites this paper
• STATE OF NEUROENDOCRINE SYSTEMS DURING ACTIVATION AND INHIBITION OF CENTRAL CHOLINERGIC SYSTEMS IN BRAIN INJURY

  2020cites this paper
• THE IMPORTANCE OF CENTRAL CHOLINERGIC SYSTEMS ACTIVATION IN TRAUMATIC BRAIN INJURY

  2020cites this paper
• Conventional and novel pharmacological approaches to treat dopamine-related disorders. Focus on Parkinson's disease and schizophrenia.

  2020cites this paper
• Retinal correlates of psychiatric disorders

  2020cites this paper
• Morphological state of the cerebral cortex in experimental traumatic brain injury against the activation and blockade of cholinergic systems

  2020cites this paper
• Dopamine D3 Receptor Heteromerization: Implications for Neuroplasticity and Neuroprotection

  2020cites this paper
• Activation of nicotinic acetylcholine receptors induces potentiation and synchronization within in vitro hippocampal networks

  2019cites this paper
• Nicotine is neuroprotective to neonatal neurons of sympathetic ganglion in rat.

  2019cites this paper
• Age- and Nicotine-Associated Gene Expression Changes in the Hippocampus of APP/PS1 Mice

  2019cites this paper
• Anti-inflammatory and antioxidant effects of muscarinic acetylcholine receptor (mAChR) activation in the rat hippocampus

  2019influential citation
• Nicotinic acetylcholine receptors in experimental models of Parkinson’s disease and levodopa-induced dyskinesia : focus on α5 subunit-containing receptors

  2019influential citation
• Functional α7Î22 Nicotinic Acetylcholine Receptors Expressed In Hippocampal Interneurons Exhibit High Sensitivity To Pathological Level Of Amyloid Î2 Peptides

  2019cites this paper
• Nicotine, Neural Plasticity, and Nicotine's Therapeutic Potential

  2019cites this paper
• In vivo imaging of Α7 nicotinic receptors as a novel method to monitor neuroinflammation after cerebral ischemia

  2018cites this paper
• Heat shock protein (Hsp) regulation by muscarinic acetylcholine receptor (mAChR) activation in the rat hippocampus

  2018cites this paper
• Nicotinic Acetylcholine Receptors in Regulation of Pathology of Cerebrovascular Disorders

  2018cites this paper
• Nicotinic Acetylcholine Receptor Signaling in Neuroprotection

  2018cites this paper
• 5 Neuroprotection and Pain Management

  2018cites this paper
• LY2087101 and dFBr share transmembrane binding sites in the (α4)3(β2)2 Nicotinic Acetylcholine Receptor

  2018cites this paper
• Additive Effect of Cigarette Smoking on Gray Matter Abnormalities in Schizophrenia

  2017cites this paper
• Existence of muscarinic acetylcholine receptor (mAChR) and fibroblast growth factor receptor (FGFR) heteroreceptor complexes and their enhancement of neurite outgrowth in neural hippocampal cultures.

  2017cites this paper
• Recent advances in discovery and development of natural products as source for anti-Parkinson's disease lead compounds.

  2017cites this paper
• Chronic nicotine differentially affects murine transcriptome profiling in isolated cortical interneurons and pyramidal neurons

  2017cites this paper
• Varenicline improves motor and cognitive deficits and decreases depressive‐like behaviour in late‐stage YAC128 mice

  2017cites this paper
• Preclinical abuse liability assessment of ABT‐126, an agonist at the &agr;7 nicotinic acetylcholine receptor (nAChR)

  2017cites this paper
• Smoking-Relevant Nicotine Concentration Attenuates the Unfolded Protein Response in Dopaminergic Neurons

  2016cites this paper
• Regulation of Gait and Balance: The Underappreciated Role of Neuronal Nicotinic Receptor Agonists.

  2016cites this paper
• Novel multifunctional pharmacology of lobinaline, the major alkaloid from Lobelia cardinalis.

  2016cites this paper
• The Potential Effect of Caffeine and Nicotine Co-administration againstAluminum-induced Alzheimer's disease in Rats

  2016cites this paper
• In Vivo PET Imaging of the α4β2 Nicotinic Acetylcholine Receptor As a Marker for Brain Inflammation after Cerebral Ischemia

  2015cites this paper
• TARGET-DIRECTED BIOSYNTHETIC EVOLUTION: REDIRECTING PLANT EVOLUTION TO GENOMICALLY OPTIMIZE A PLANT’S PHARMACOLOGICAL PROFILE

  2015influential citation
• Chronic nicotine administration does not alter cognitive or mood associated behavioural parameters.

  2015cites this paper
• Association between cigarette smoking and Parkinson's disease: A meta-analysis.

  2015cites this paper
• Nicotine inhibits hippocampal and striatal acetylcholinesterase activities, and demonstrates dual action on adult neuronal proliferation and maturation.

  2015cites this paper
• Gender differences in the effect of tobacco use on brain phosphocreatine levels in methamphetamine-dependent subjects

  2015cites this paper
• Desformylflustrabromine Modulates α4β2 Neuronal Nicotinic Acetylcholine Receptor High- and Low-Sensitivity Isoforms at Allosteric Clefts Containing the β2 Subunit

  2015cites this paper
• Potential Use of Nicotinic Receptor Agonists for the Treatment of Chemotherapy-Induced Cognitive Deficits

  2015cites this paper
• Evaluation of Chronic Oral Nicotine Treatment in Food Consumption, Body Weight and (125I) Epibatidine Binding in Adult Mice

  2015cites this paper
• Desformylflustrabromine Modulates a4b2 Neuronal Nicotinic Acetylcholine Receptor High- and Low-Sensitivity Isoforms at Allosteric Clefts Containing the b2 Subunit

  2015cites this paper
• Involvement of α7 nAChR subtype in rat oxaliplatin-induced neuropathy: effects of selective activation.

  2014cites this paper
• Smoking and increased Alzheimer's disease risk: A review of potential mechanisms

  2014cites this paper
• Protracted treatment with MDMA induces heteromeric nicotinic receptor up-regulation in the rat brain: an autoradiography study.

  2014cites this paper
• Different Resting-State Functional Connectivity Alterations in Smokers and Nonsmokers with Internet Gaming Addiction

  2014cites this paper
• ABT‐089 and ABT‐894 reduce levodopa‐induced dyskinesias in a monkey model of Parkinson's disease

  2014cites this paper
• Interactions between cholinergic and fibroblast growth factor receptors in brain trophism and plasticity.

  2014cites this paper
• Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial

  2014cites this paper
• Pharmacological chaperoning of nAChRs: a therapeutic target for Parkinson's disease.

  2014cites this paper
• Ending tobacco-caused mortality and morbidity: the case for performance standards for tobacco products

  2013cites this paper
• MOL084863 1176..1189

  2013cites this paper
• Alcohol and nicotinic acetylcholine receptors

  2013cites this paper
• Système cholinergique et modulation de la transmission nociceptive spinale

  2013cites this paper
• α4β2 Nicotinic receptors play a role in the nAChR-mediated decline in L-dopa-induced dyskinesias in parkinsonian rats.

  2013cites this paper
• Nicotine reduces established levodopa‐induced dyskinesias in a monkey model of Parkinson's disease

  2013cites this paper
• Nicotine is a pain reliever in trauma- and chemotherapy-induced neuropathy models.

  2013cites this paper
• Nicotine-Induced Structural Plasticity in Mesencephalic Dopaminergic Neurons Is Mediated by Dopamine D3 Receptors and Akt-mTORC1 Signaling

  2013cites this paper
• trial Galantamine efficacy and tolerability as an augmentative therapy in autistic children : A randomized

  2013cites this paper
• Multiple Interaction Regions in the Orthosteric Ligand Binding Domain of the α7 Neuronal Nicotinic Acetylcholine Receptor

  2012cites this paper
• α7 Nicotinic acetylcholine receptor agonist attenuates neuropathological changes associated with intracerebral hemorrhage in mice.

  2012cites this paper
• Potential Contribution of Aromatase Inhibition to the Effects of Nicotine and Related Compounds on the Brain

  2012cites this paper
• Galantamine increases hippocampal insulin-like growth factor 2 expression via α7 nicotinic acetylcholine receptors in mice

  2012cites this paper
• Neuroprotection and Pain Management

  2012cites this paper
• Similar hyporesponsiveness of the dorsomedial prefrontal cortex in problem gamblers and heavy smokers during an inhibitory control task.

  2012cites this paper
• Establishment and validation of hippocampal LTP for characterization of memory enhancing drugs as potential treatment of Alzheimer’s disease

  2012cites this paper
• Functional α7β2 nicotinic acetylcholine receptors expressed in hippocampal interneurons exhibit high sensitivity to pathological level of amyloid β peptides

  2012cites this paper
• Synthesis of Selective Agonists for the α7 Nicotinic Acetylcholine Receptor with In Situ Click-Chemistry on Acetylcholine-Binding Protein Templates

  2012cites this paper
• Synthesizing Selective Agonists for the α 7 Nicotinic Receptor with in situ Click-Chemistry on Acetylcholine Binding Protein Templates

  2012cites this paper
• Nicotine as a potential neuroprotective agent for Parkinson's disease

  2012cites this paper
• Functional Nicotinic Acetylcholine Receptors Containing α6 Subunits Are on GABAergic Neuronal Boutons Adherent to Ventral Tegmental Area Dopamine Neurons

  2011cites this paper
• The effects of dietary choline

  2011cites this paper
• Fluctuations in Endogenous Kynurenic Acid Control Hippocampal Glutamate and Memory

  2011cites this paper
• Positive and Negative Effects of Alcohol and Nicotine and Their Interactions: A Mechanistic Review

  2011cites this paper
• Differential effects of subtype-specific nicotinic acetylcholine receptor agonists on early and late hippocampal LTP.

  2011cites this paper
• Therapeutic Effect of Nicotine in a Mouse Model of Intracerebral Hemorrhage

  2011cites this paper
• Establishment and validation of hippocampal LTP for characterization of memory enhancing drugs as potential treatment of Alzheimers disease

  2011cites this paper
• Interacció dels derivats amfetamínics amb els receptors nicotínics: Aspectes moleculars i funcionals

  2011cites this paper
• Cholinergic receptor subtypes and their role in cognition, emotion, and vigilance control: An overview of preclinical and clinical findings

  2011cites this paper
• Analgesic and Antineuropathic Drugs Acting Through Central Cholinergic Mechanisms

  2011cites this paper
• The effects of 3,4-methylenedioxymethamphetamine (MDMA) on nicotinic receptors: intracellular calcium increase, calpain/caspase 3 activation, and functional upregulation.

  2010cites this paper
• Role of nicotinic acetylcholine receptor subtypes α4β2 and α7 in nicotine-ethanol interaction and cross-tolerance: functional correlation with cerebellar nitric oxide

  2010cites this paper
• Investigational Medications for Treatment of Patients With Alzheimer Disease

  2010cites this paper
• Environmental Epidemiology of Essential Tremor Elan

  2010cites this paper
• Smoking, nicotine and neuropsychiatric disorders.

  2010cites this paper
• Chronic nicotine exposure produces lateralized, age‐dependent dendritic remodeling in the rodent basolateral amygdala

  2010cites this paper
• Brain activation patterns associated with cue reactivity and craving in abstinent problem gamblers, heavy smokers and healthy controls: an fMRI study

  2010cites this paper
• Cotinine

  2010cites this paper
• Effect of Cigarette Smoking on Disease Progression in Idiopathic Parkinson's Disease Patients

  2010cites this paper
• Regulation of the nicotinic receptor alpha7 subunit by chronic stress and corticosteroids.

  2010cites this paper
• Embyronic Nicotine Exposure and Its Impact on Spinal Neuron Development in Zebrafish

  2010cites this paper
• In Vivo Pharmacological Characterization of a Novel Selective α7 Neuronal Nicotinic Acetylcholine Receptor Agonist ABT-107: Preclinical Considerations in Alzheimer's Disease

  2010cites this paper
• Protective effect of alpha7 nAChR: Behavioural and morphological features on neuropathy

  2010cites this paper
• [Nicotine as an antidepressant and regulator of sleep in subjects with depression].

  2009cites this paper